Dyskeratosis congenita (autosomal recessive)

Overview

Dyskeratosis congenita (autosomal recessive) represents a form of telomere biology disorder in which cells cannot properly maintain the protective structures at chromosome ends. Telomeres naturally shorten with each cell division, but in this condition accelerated shortening occurs because key maintenance machinery is defective [PMID:17377820]. This premature exhaustion particularly affects rapidly dividing tissues including blood-forming cells in the bone marrow, skin and the mucosal lining of the digestive tract.

The condition is rare, though exact prevalence figures in the UK population are not well established. Clinical features typically emerge in childhood or adolescence, though timing and severity vary considerably between affected individuals. The autosomal recessive form occurs when someone inherits pathogenic variants in both copies of one of several causative genes, affecting males and females equally [PMID:23992924]. Without appropriate monitoring and intervention, progressive bone marrow failure poses significant health risks.

Symptoms & clinical features

The characteristic clinical triad comprises abnormal skin pigmentation (often a lacy, reticular pattern on the neck and upper chest), dystrophic fingernails and toenails that may be ridged or absent, and white patches (leukoplakia) inside the mouth [PMID:17377820]. However, not everyone displays all three features, and presentation can be variable even within families.

Bone marrow failure typically develops during the first or second decade of life, manifesting as progressive cytopenias - reduced numbers of red blood cells, white blood cells and platelets. This leads to fatigue, increased infection susceptibility, easy bruising and abnormal bleeding. Additional features may include dental problems with early tooth loss, sparse or prematurely grey hair, eye abnormalities such as excessive tearing or abnormal eyelashes, lung disease with pulmonary fibrosis, liver cirrhosis, and developmental concerns including short stature or learning difficulties in some cases [PMID:23992924]. Gastrointestinal problems and osteoporosis can also occur.

Video: Genetics 101

Affected organs

The bone marrow bears the most clinically significant impact, with progressive failure affecting production of all blood cell lineages. This haematological involvement dominates the clinical course and represents the primary cause of morbidity. The skin shows characteristic pigmentary changes and premature ageing features, whilst nails demonstrate dystrophic changes ranging from ridging to complete absence.

The oral mucosa frequently develops leukoplakia, which carries malignant transformation risk. Pulmonary involvement can progress to restrictive lung disease and fibrosis. The liver may develop cirrhosis or vascular abnormalities. The gastrointestinal tract can be affected throughout its length, with oesophageal strictures occasionally reported. Bone density is often reduced, and the immune system may show functional impairment beyond simple low white cell counts.

Blood & bone marrow

Haematological involvement

Cellular impact

Mechanism at cellular level

Risks & severity

Severity exists on a spectrum from relatively mild presentations with late-onset cytopenias to severe early-onset disease with multisystem involvement. Progressive bone marrow failure represents the most serious complication, with many affected individuals eventually requiring haematopoietic stem cell transplantation. Without transplant, aplastic anaemia can be fatal.

Individuals with dyskeratosis congenita face substantially elevated cancer risks compared to the general population. Particular concern exists for myelodysplastic syndrome, acute myeloid leukaemia, and squamous cell carcinomas affecting the head, neck, gastrointestinal tract and anogenital regions. Malignancy risk is considerably higher than in unaffected populations, with solid tumours representing a significant long-term concern. Age of onset for complications varies widely - some individuals develop significant problems in childhood whilst others remain relatively stable into adulthood before experiencing progression. Pulmonary fibrosis, when present, significantly impacts quality of life and can be progressive.

Genetic causes

Autosomal recessive dyskeratosis congenita results from pathogenic variants in genes encoding components of the telomerase complex or proteins involved in telomere maintenance. The causative genes include NHP2, NOP10, PARN, RTEL1 and WRAP53. These genes produce proteins with critical roles in either the telomerase enzyme complex that adds repetitive sequences to chromosome ends, or in regulatory processes governing telomere structure and replication.

NHP2 and NOP10 encode core components of the H/ACA ribonucleoprotein complex, which is essential for telomerase function [PMID:17377820]. PARN encodes a ribonuclease involved in processing telomerase RNA. RTEL1 produces a helicase that helps resolve complex DNA structures during telomere replication and prevents inappropriate recombination. WRAP53 encodes a protein crucial for telomerase trafficking and Cajal body formation where telomerase assembly occurs [PMID:23992924]. When pathogenic variants disrupt these proteins, telomeres shorten excessively with each cell division, eventually triggering cellular senescence or death particularly in rapidly dividing tissues.

• NHP2
  NHP2 ribonucleoprotein
• NOP10
  NOP10 ribonucleoprotein
• PARN
  poly(A)-specific ribonuclease
• RTEL1
  regulator of telomere elongation helicase 1
• WRAP53
  WD repeat containing antisense to TP53

Inheritance pattern

This form of dyskeratosis congenita follows autosomal recessive inheritance, meaning affected individuals carry pathogenic variants in both copies of one causative gene - one inherited from each parent. Parents are typically unaffected carriers, each possessing one working gene copy and one non-functioning copy. Carriers do not usually show symptoms, though some may have slightly shorter telomeres than population averages.

When both parents are carriers for the same gene, each pregnancy carries a 25% chance of producing an affected child, a 50% chance of a carrier child, and a 25% chance of a child inheriting two working copies. Male and female children have equal likelihood of being affected. Siblings of affected individuals have a 50% chance of being carriers. Genetic counselling can clarify risks for extended family members and discuss reproductive options including prenatal or preimplantation genetic diagnosis for carrier couples.

Diagnosis & testing

Diagnosis combines clinical assessment with genetic testing. The characteristic mucocutaneous triad prompts consideration, particularly when accompanied by unexplained cytopenias. Blood tests revealing low counts across multiple lineages (pancytopenia) alongside characteristic physical findings raise suspicion. Telomere length measurement in lymphocytes showing values below the first centile for age provides supportive evidence.

Confirmation requires genetic testing identifying biallelic pathogenic variants in NHP2, NOP10, PARN, RTEL1 or WRAP53. Within the NHS Genomic Medicine Service, testing is accessed through clinical genetics services. Relevant PanelApp panels include the Telomeropathies panel (R419) which facilitates appropriate gene analysis. Referral typically comes from haematology or clinical genetics following recognition of suspicious features. Bone marrow examination may show characteristic hypocellularity, though this finding is not specific.

Management & lifestyle

Management centres on monitoring for complications and providing supportive care through specialist haematology and clinical genetics services. Regular blood count monitoring enables early detection of worsening cytopenias. Prophylactic antibiotics and antifungal medications may reduce infection risks in those with significant neutropenia. Transfusion support with red cells or platelets addresses symptomatic anaemia or bleeding risk.

Haematopoietic stem cell transplantation remains the only curative option for bone marrow failure, though the procedure carries significant risks in this population due to increased sensitivity to conditioning regimens and complications. Reduced-intensity protocols are typically preferred. Surveillance for malignancy includes regular skin and oral cavity examination, with biopsy of suspicious lesions. Pulmonary function testing monitors for lung involvement. Avoidance of smoking and excessive sun exposure is strongly advised given elevated cancer risks. Individuals should discuss any new medications with their specialist team, as some drugs may impact telomere biology or bone marrow function. Genetic counselling provides information about inheritance patterns and supports family planning decisions.

UK care pathway

Within the NHS Genomic Medicine Service, individuals with suspected dyskeratosis congenita typically enter care through referral to clinical genetics or specialist haematology services. Genetic testing is available through the Telomeropathies (R419) testing pathway on the National Genomic Test Directory. Following genetic confirmation, multidisciplinary management coordinates input from haematology, dermatology, respiratory medicine, gastroenterology and other specialists as needed. Access to genetic counsellors supports affected individuals and families in understanding inheritance, implications for relatives, and reproductive choices. Regional genomic medicine centres coordinate genetic testing and link patients with appropriate clinical services.

Related conditions

Dyskeratosis congenita exists within a spectrum of telomere biology disorders sharing overlapping features. X-linked dyskeratosis congenita, caused by pathogenic variants in DKC1, presents similarly but affects predominantly males with more severe manifestations. Hoyeraal-Hreidarsson syndrome represents a severe form with additional features including cerebellar hypoplasia and immunodeficiency, sometimes resulting from variants in the same genes. Coats plus syndrome, linked to CTC1 variants, shares bone marrow failure and includes distinctive retinal changes. Other conditions featuring bone marrow failure such as Fanconi anaemia or Shwachman-Diamond syndrome require differentiation, though these have distinct genetic causes and different additional features.

Frequently asked questions